BR0210195A - Imidazol substituìdo com arilazo para o tratamento da incontinência urinária por tensão - Google Patents

Imidazol substituìdo com arilazo para o tratamento da incontinência urinária por tensão

Info

Publication number
BR0210195A
BR0210195A BR0210195-5A BR0210195A BR0210195A BR 0210195 A BR0210195 A BR 0210195A BR 0210195 A BR0210195 A BR 0210195A BR 0210195 A BR0210195 A BR 0210195A
Authority
BR
Brazil
Prior art keywords
treatment
urinary incontinence
arylazo
substituted imidazole
stress urinary
Prior art date
Application number
BR0210195-5A
Other languages
English (en)
Inventor
Robert William Gristwood
David Cavalla
Original Assignee
Robert Edward Perry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Edward Perry filed Critical Robert Edward Perry
Publication of BR0210195A publication Critical patent/BR0210195A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"IMIDAZOL SUBSTITUìDO COM ARILAZO PARA O TRATAMENTO DA INCONTINêNCIA URINáRIA POR TENSãO". Um imidazol substituído com arilazo tendo atividade de estimulação alfa adrenérgica é útil para o tratamento da incontinência urinária por tensão.
BR0210195-5A 2001-06-08 2002-06-07 Imidazol substituìdo com arilazo para o tratamento da incontinência urinária por tensão BR0210195A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0114008.6A GB0114008D0 (en) 2001-06-08 2001-06-08 New therapautic use
PCT/GB2002/002635 WO2002100414A1 (en) 2001-06-08 2002-06-07 Arylazo-substituted imidazole for the treatment of stress urinary incontinence

Publications (1)

Publication Number Publication Date
BR0210195A true BR0210195A (pt) 2004-07-27

Family

ID=9916211

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210195-5A BR0210195A (pt) 2001-06-08 2002-06-07 Imidazol substituìdo com arilazo para o tratamento da incontinência urinária por tensão

Country Status (13)

Country Link
US (1) US20040242547A1 (pt)
EP (1) EP1399167A1 (pt)
JP (1) JP2005500285A (pt)
KR (1) KR20040030654A (pt)
CN (1) CN1234367C (pt)
AU (1) AU2002311445B2 (pt)
BR (1) BR0210195A (pt)
CA (1) CA2449957A1 (pt)
GB (1) GB0114008D0 (pt)
MX (1) MXPA03011226A (pt)
RU (1) RU2004100228A (pt)
WO (1) WO2002100414A1 (pt)
ZA (1) ZA200309473B (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056123B2 (ja) * 1979-07-30 1985-12-09 持田製薬株式会社 浮腫・低血圧・心不全および粘膜充血治療用剤
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
US6323231B1 (en) * 2000-02-17 2001-11-27 Abbott Laboratories Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence

Also Published As

Publication number Publication date
US20040242547A1 (en) 2004-12-02
EP1399167A1 (en) 2004-03-24
JP2005500285A (ja) 2005-01-06
ZA200309473B (en) 2005-03-23
WO2002100414A1 (en) 2002-12-19
AU2002311445B2 (en) 2005-08-25
CA2449957A1 (en) 2002-12-19
CN1541099A (zh) 2004-10-27
GB0114008D0 (en) 2001-08-01
CN1234367C (zh) 2006-01-04
RU2004100228A (ru) 2005-06-10
MXPA03011226A (es) 2004-03-26
KR20040030654A (ko) 2004-04-09

Similar Documents

Publication Publication Date Title
DE60233212D1 (de) Immunstimulierende beschichtung für chirurgische vorrichtungen
BR9608049A (pt) Emprego de agonistas de alfa 1l para o tratamento da incontinênica urinária
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
BR0311591A (pt) 1-(aminoalquil)-2-sulfonilazindóis como ligandos de 5-hidroxitriptamina-6
BR0309278A (pt) Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto
ATE363250T1 (de) Wirbelsäulenprothesen
ATE311148T1 (de) Chirurgische vorrichtungen
DE69724811D1 (de) Pentafluorobenzensulfonamide und analoge
TR200200706T2 (tr) Nöropatik ağrı tedavisi için retigabin kullanımı.
CY1105705T1 (el) Παραγωγα ινδολυλαλκυλαμινης σαν συνδετηρες 5-υδροξυτρυπταμινης-6
BRPI0414794A (pt) oxadiazolidinadionas substituìdas
DE60044335D1 (de) 16-phenoxy-lipoxin analoge zur medizinischen verwendung
UY26677A1 (es) Heterociclos que son inhibidores de la enzima impdh
ES2134929T3 (es) Derivados de pirrolo-piridina como ligandos para receptores de dopamina.
BR9805151A (pt) Construções de ácidos nucleicos para a terapia do gene cuja atividade é afetada por inbidores de cinases dependentes de ciclina.
ATE439363T1 (de) Imidazo 2,1-b -1,3,4-thiadiazole sulfonamides
EE200100478A (et) Vahend artriitilise haiguse raviks
BR0307903A (pt) derivados de arilsulfona
DE60015508D1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
DE69934294D1 (de) Verwendung eines antimikrobiellen mittels so wie taurolidine oder taurultam zur herstellung eines arzneimittels zur behandlung einer nosokomialen mikrobiellen infektion
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
BR0210195A (pt) Imidazol substituìdo com arilazo para o tratamento da incontinência urinária por tensão
BRPI0408468A (pt) métodos para preparação e uso de 1(alfa),24(s)-diidroxivitamina d2
ATE314058T1 (de) Verwendung von 5ht3 antagonisten zur fundusentspannung
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: ARACHNOVA THERAPEUTICS LTD. (GB), SOSEI CO. LTD (JP)

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2094 DE 22/02/2011.